All Stories

  1. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience

    Article • BJU International, April 2015, Wiley

    Professor Mark Frydenberg

  2. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry

    Article • BJU International, April 2015, Wiley

    Professor Mark Frydenberg

  3. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery

    Article • BJU International, March 2015, Wiley

    Professor Mark Frydenberg

  4. Assessing Expression of MUC1 and ZAG Protein Biomarkers in Prostate Biopsies Improves Prediction of Adverse Pathology Following Radical Prostatectomy

    Article • The Open Prostate Cancer Journal, March 2015, Bentham Science Publishers

    Professor Mark Frydenberg

  5. Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

    Article • European Urology, March 2015, Elsevier

    Professor Mark Frydenberg

  6. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer

    Article • European Urology, March 2015, Elsevier

    Professor Mark Frydenberg, Dr Neil E Martin

  7. Prostate cancer screening in Primary Health Care: the current state of affairs

    Article • SpringerPlus, February 2015, Springer Science + Business Media

    Professor Mark Frydenberg

  8. Penthrox alone versus Penthrox plus periprostatic infiltration of local analgesia for analgesia in transrectal ultrasound-guided prostate biopsy

    Article • Australian and New Zealand Journal of Surgery, February 2015, Wiley

    Professor Mark Frydenberg

  9. Primary apocrine adenocarcinoma of scrotum suspected as urothelial carcinoma metastasis: A clinical and pathological dilemma

    Article • Urology Annals, January 2015, Medknow

    Professor Mark Frydenberg

  10. P007 Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian transperineal biopsy collaboration experience

    Article • European Urology Supplements, November 2014, Elsevier

    Professor Mark Frydenberg

  11. Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancer

    Article • BJU International, October 2014, Wiley

    Professor Mark Frydenberg

  12. Long-term outcome of radical cystectomy – metropolitan Australia experience

    Article • Journal of Clinical Urology, October 2014, SAGE Publications

    Professor Mark Frydenberg

  13. Care beyond prostate cancer—improving patient outcomes

    Article • Nature Reviews Urology, September 2014, Springer Science + Business Media

    Professor Mark Frydenberg

  14. Anxiety in the management of localised prostate cancer by active surveillance

    Article • BJU International, July 2014, Wiley

    Professor Mark Frydenberg

  15. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment

    Article • The Journal of Pathology, July 2014, Wiley

    Professor Mark Frydenberg

  16. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: Correlation with histopathology

    Article • Journal of Medical Imaging and Radiation Oncology, June 2014, Wiley

    Professor Mark Frydenberg

  17. Androgen deprivation therapy complications

    Article • May 2014, Bioscientifica

    Dr Carolyn A Allan, Professor Mark Frydenberg

  18. ‘What is this active surveillance thing?’ Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option

    Article • Psycho-Oncology, May 2014, Wiley

    Professor Mark Frydenberg

  19. Mast cell interactions at tumour interface drive progression in human prostate cancer

    Article • April 2014

    Professor Mark Frydenberg

  20. 28 Current use of active surveillance in Australia – a patterns of care analysis from the Prostate Cancer Registry

    Article • European Urology Supplements, April 2014, Elsevier

    Professor Mark Frydenberg

  21. MP46-08 SURGICAL OUTCOMES OF PATIENTS WHO FAIL ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER IN AN AUSTRALIAN POPULATION

    Article • The Journal of Urology, April 2014, Elsevier

    Professor Mark Frydenberg

  22. 652 The presence of risk factors for chronic kidney disease may diminish the benefit of partial nephrectomy for renal cell carcinoma

    Article • European Urology Supplements, April 2014, Elsevier

    Professor Mark Frydenberg

  23. Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer

    Article • BMJ Open, March 2014, BMJ

    Professor Mark Frydenberg

  24. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?

    Article • BJU International, February 2014, Wiley

    Dr Jeremy P Grummet, Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  25. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage (RAVES) trial

    Article • BJU International, February 2014, Wiley

    Professor Mark Frydenberg

  26. Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry

    Article • BJU International, February 2014, Wiley

    Professor Mark Frydenberg

  27. Rare synchronous metastases of renal cell carcinoma

    Article • Urology Annals, January 2014, Medknow

    Professor Mark Frydenberg

  28. Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma

    Article • Pathology, December 2013, Elsevier

    Professor Mark Frydenberg, Dr Anthony J Gill

  29. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

    Article • BJU International, October 2013, Wiley

    Professor Mark Frydenberg, Professor Nathan Lawrentschuk

  30. Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium

    Article • The Prostate, September 2013, Wiley

    Professor Mark Frydenberg

  31. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer

    Article • Biomaterials, July 2013, Elsevier

    Professor Mark Frydenberg

  32. Factors associated with adherence to physical activity guidelines in patients with prostate cancer

    Article • Psycho-Oncology, June 2013, Wiley

    Professor Mark Frydenberg

  33. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011

    Article • The Medical Journal of Australia, June 2013, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Professor Mark Frydenberg

  34. A Preclinical Xenograft Model Identifies Castration-Tolerant Cancer-Repopulating Cells in Localized Prostate Tumors

    Article • Science Translational Medicine, May 2013, American Association for the Advancement of Science

    Professor Mark Frydenberg

  35. A preclinical xenograft model of prostate cancer using human tumors

    Article • Nature Protocols, April 2013, Springer Science + Business Media

    Professor Mark Frydenberg

  36. 1608 SPONTANEOUS CONTRACTIONS IN THE TRANSITION ZONE OF PROSTATES FROM MEN WITH BENIGN PROSTATIC HYPERPLASIA OR ENLARGEMENT ARE NOT BLOCKED BY TAMSULOSIN

    Article • The Journal of Urology, April 2013, Elsevier

    Professor Mark Frydenberg

  37. Pre-clinical model detects castrate-resistant cancer repopulating cells in localised prostate tumours

    Article • April 2013

    Professor Mark Frydenberg

  38. 1342 PSYCHOLOGICAL STRESS ASSOCIATED WITH ACTIVE SURVEILLANCE FOR LOCALISED LOW RISK PROSTATE CANCER

    Article • The Journal of Urology, April 2013, Elsevier

    Professor Mark Frydenberg

  39. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy

    Article • Psycho-Oncology, March 2013, Wiley

    Professor Mark Frydenberg

  40. 946 Identification of castrate-resistant cancer repopulating cells in localised prostate tumours

    Article • European Urology Supplements, March 2013, Elsevier

    Professor Mark Frydenberg

  41. A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer

    Article • BMC Cancer, February 2013, Springer Science + Business Media

    Professor Mark Frydenberg

  42. Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy

    Article • Current Urology, January 2013, Wolters Kluwer Health

    Professor Mark Frydenberg

  43. Informed prostate cancer risk-adjusted testing: a new paradigm

    Article • BJU International, November 2012, Wiley

    Professor Mark Frydenberg

  44. The ‘green whistle’: A novel method of analgesia for transrectal prostate biopsy

    Article • BJU International, November 2012, Wiley

    Professor Mark Frydenberg

  45. Giant obturator schwannoma: an unusual finding in a patient with prostate cancer

    Article • Australian and New Zealand Journal of Surgery, November 2012, Wiley

    Professor Mark Frydenberg

  46. The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer

    Article • BJU International, November 2012, Wiley

    Professor Mark Frydenberg

  47. Utility of RhoC and ZAG protein expression as biomarkers for prediction of pSa failure following radical prostatectomy for high grade prostate cancer

    Article • Pathology, October 2012, Elsevier

    Professor Mark Frydenberg

  48. Estrogen Receptor β Activation Impairs Prostatic Regeneration by Inducing Apoptosis in Murine and Human Stem/Progenitor Enriched Cell Populations

    Article • PLoS ONE, July 2012, PLOS

    Professor Mark Frydenberg

  49. 383 Apoptosis and Regenerative Potential in Castrate-resistant Stem Cells of the Prostate Gland Regulated by Estrogen Receptor Beta

    Article • European Journal of Cancer, July 2012, Elsevier

    Professor Mark Frydenberg

  50. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status

    Article • Stem Cells, May 2012, Wiley

    Professor Mark Frydenberg

  51. Active surveillance for prostate cancer: an Australian experience

    Article • BJU International, March 2012, Wiley

    Professor Mark Frydenberg

  52. Monitoring cardiovascular health in men with prostate cancer treated with androgen deprivation therapy

    Article • International Journal of Urological Nursing, February 2012, Wiley

    Professor Mark Frydenberg

  53. Laparoscopic versus open prostatectomy for the treatment of localised prostate cancer

    Article • February 2012, Wiley

    Professor Mark Frydenberg

  54. Primary Culture and Propagation of Human Prostate Epithelial Cells

    Article • January 2012, Springer Science + Business Media

    Professor Mark Frydenberg

  55. Primary Myeloid Sarcoma of the Urinary Bladder

    Article • UroToday International Journal, January 2012, Digital Science Press (Urotoday International Journal)

    Professor Mark Frydenberg

  56. Brief Report: A Bioassay to Identify Primary Human Prostate Cancer Repopulating Cells

    Article • Stem Cells, July 2011, Wiley

    Professor Mark Frydenberg

  57. Editorial comment: Equity in prostate cancer screening and management

    Article • BJU International, April 2011, Wiley

    Professor Mark Frydenberg

  58. Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: experience from Australasia

    Article • BJU International, April 2011, Wiley

    Professor Mark Frydenberg

  59. Contributors

    Article • January 2011, Elsevier

    Professor Mark Frydenberg

  60. Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family

    Article • Familial Cancer, December 2010, Springer Science + Business Media

    Professor Mark Frydenberg

  61. Renal Vein Leiomyosarcoma

    Article • BJUI, October 2010, Wiley

    Professor Mark Frydenberg

  62. Contributors

    Article • January 2010, Elsevier

    Professor Mark Frydenberg

  63. Urogenital problems

    Article • January 2010, Elsevier

    Professor Mark Frydenberg

  64. Groin, scrotum and abdominal wall problems

    Article • January 2010, Elsevier

    Professor Mark Frydenberg

  65. Characterization of the pattern of sexual function after brachytherapy or radical prostatectomy suggests the importance of expectation management

    Article • Brachytherapy, April 2008, Elsevier

    Professor Mark Frydenberg

  66. Long-term experience of residual symptoms following treatment for localized prostate cancer: An Australian sample

    Article • Asia-Pacific Journal of Clinical Oncology, December 2007, Wiley

    Professor Mark Frydenberg

  67. Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy

    Article • International braz j urol, August 2007, FapUNIFESP (SciELO)

    Professor Mark Frydenberg

  68. Prostate Cancer. The Disease Treatment Options and Outcomes - by Prim Rashid

    Article • Australian and New Zealand Journal of Surgery, March 2007, Wiley

    Professor Mark Frydenberg

  69. Assessing mood and general health-related quality of life among men treated in Australia for localized prostate cancer

    Article • International Journal of Urology, February 2007, Wiley

    Professor Mark Frydenberg

  70. Psychological adjustment of survivors of localised prostate cancer: investigating the role of dyadic adjustment, cognitive appraisal and coping style

    Article • Psycho-Oncology, January 2007, Wiley

    Professor Mark Frydenberg

  71. The Relative Roles of Follicle-Stimulating Hormone and Luteinizing Hormone in Maintaining Spermatogonial Maturation and Spermiation in Normal Men

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2006, Endocrine Society

    Professor Mark Frydenberg

  72. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective

    Article • BJU International, June 2006, Wiley

    Professor Mark Frydenberg

  73. 33
Development and maturation of human prostate from embryonic stem cellsin vivo

    Article • BJU International, March 2006, Wiley

    Professor Mark Frydenberg

  74. MANAGEMENT OF MUSCLE-INVASIVE BLADDER CANCER IN VICTORIA, 1990-1995

    Article • Australian and New Zealand Journal of Surgery, March 2006, Wiley

    Professor Mark Frydenberg

  75. Sex steroids modulate α1-adrenoceptor-stimulated Ca2+ elevation in human cultured prostatic stromal cells

    Article • The Prostate, January 2006, Wiley

    Professor Mark Frydenberg

  76. MANAGEMENT OF SUPERFICIAL BLADDER CANCER IN VICTORIA: 1990 AND 1995

    Article • Australian and New Zealand Journal of Surgery, May 2005, Wiley

    Professor Mark Frydenberg

  77. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer

    Article • Urology, September 2004, Elsevier

    Professor Mark Frydenberg

  78. Your Guide to Prostate Cancer − the Disease, Treatment Options and Outcomes.

    Article • Australian and New Zealand Journal of Surgery, June 2004, Wiley

    Professor Mark Frydenberg

  79. Local Aromatase Expression in Human Prostate Is Altered in Malignancy

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2004, Endocrine Society

    Professor Mark Frydenberg

  80. Prostate Cancer: Diagnosis and Surgical Treatment.

    Article • Australian and New Zealand Journal of Surgery, March 2004, Wiley

    Professor Mark Frydenberg

  81. A1 and A2A adenosine receptor modulation of α 1 -adrenoceptor-mediated contractility in human cultured prostatic stromal cells

    Article • British Journal of Pharmacology, January 2004, Wiley

    Professor Mark Frydenberg

  82. Gyrus™ bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up

    Article • Prostate Cancer and Prostatic Diseases, June 2003, Springer Science + Business Media

    Professor Mark Frydenberg

  83. Role of pelvic lymphadenectomy as an adjunct to radical prostatectomy

    Article • Australian and New Zealand Journal of Surgery, May 2003, Wiley

    Professor Mark Frydenberg

  84. Phytoestrogens

    Article • January 2003, Elsevier

    Professor Mark Frydenberg

  85. Outcome, morbidity, and prognostic factors in post-prostatectomy radiotherapy: an Australian multicenter study

    Article • Urology, January 2003, Elsevier

    Professor Mark Frydenberg

  86. Isolated high grade prostatic intraepithelial neoplasia may not predict future prostatic malignancy

    Article • Evidence-based Oncology, December 2002, Elsevier

    Professor Mark Frydenberg

  87. Poor prognosis germ-cell tumors: An unresolved challenge

    Article • Seminars in Urologic Oncology, November 2002, Elsevier

    Professor Mark Frydenberg

  88. Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community

    Article • Internal Medicine Journal, May 2002, Wiley

    Professor Mark Frydenberg

  89. Effects of Testosterone Plus Medroxyprogesterone Acetate on Semen Quality, Reproductive Hormones, and Germ Cell Populations in Normal Young Men

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2002, Endocrine Society

    Professor Mark Frydenberg

  90. Hypermethylation of the Inhibin α-Subunit Gene in Prostate Carcinoma

    Article • Molecular Endocrinology, February 2002, Endocrine Society

    Professor Mark Frydenberg

  91. Investigations with FDG-PET Scanning in Prostate Cancer Show Limited Value for Clinical Practice

    Article • Acta Oncologica, January 2002, Taylor & Francis

    Professor Mark Frydenberg

  92. Outcome, morbidity and prognostic factors in post-prostatectomy radiotherapy: An Australian multi-center study

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2001, Elsevier

    Professor Mark Frydenberg

  93. Testosterone- and phorbol ester-stimulated proliferation in human cultured prostatic stromal cells

    Article • Cellular Signalling, October 2001, Elsevier

    Professor Mark Frydenberg

  94. Nephron-sparing surgery for small incidental renal cell carcinoma

    Article • Australian and New Zealand Journal of Surgery, June 2001, Wiley

    Professor Mark Frydenberg

  95. The Metaplastic Effects of Estrogen on Mouse Prostate Epithelium: Proliferation of Cells with Basal Cell Phenotype1

    Article • Endocrinology, June 2001, Endocrine Society

    Professor Mark Frydenberg

  96. Nephron-sparing surgery for small incidental renal cell carcinoma

    Article • Australian and New Zealand Journal of Surgery, June 2001, Wiley

    Professor Mark Frydenberg

  97. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects

    Article • Cancer, January 2001, Wiley

    Professor Mark Frydenberg

  98. Intrarenal cystic mass with pelviureteral junction obstruction

    Article • Urology, May 2000, Elsevier

    Professor Mark Frydenberg

  99. Prostatic Cancer

    Article • The Journal of Urology, January 1999, Elsevier

    Professor Mark Frydenberg

  100. Prostatic Cancer: Role of Color Doppler Imaging in Transrectal Sonography

    Article • The Journal of Urology, January 1999, Elsevier

    Professor Mark Frydenberg

  101. Prostatic cancer: role of color Doppler imaging in transrectal sonography.

    Article • American Journal of Roentgenology, July 1998, American Roentgen Ray Society

    Professor Mark Frydenberg

  102. Prostate cancer diagnosis and management

    Article • The Lancet, June 1997, Elsevier

    Professor Mark Frydenberg

  103. Homologous blood transfusion in patients with prostate cancer: No effect on tumor progression or survival

    Article • Urology, June 1994, Elsevier

    Professor Mark Frydenberg

  104. Radical prostatectomy for pathologic stage C prostate cancer: Influence of pathologic variables and adjuvant treatment on disease outcome

    Article • Urology, September 1993, Elsevier

    Professor Mark Frydenberg

  105. Malignant Phaeochromocytoma of the Bladder-Active or Inactive

    Article • British Journal of Urology, May 1991, Wiley

    Professor Mark Frydenberg

  106. Renal Oncocytomas-An Australian Experience

    Article • British Journal of Urology, April 1991, Wiley

    Professor Mark Frydenberg

  107. BLUNT ABDOMINAL AORTIC TRAUMA

    Article • Australian and New Zealand Journal of Surgery, May 1990, Wiley

    Professor Mark Frydenberg

  108. Calculus in Urethral Diverticulum Formed upon a Nylon Suture

    Article • British Journal of Urology, December 1988, Wiley

    Professor Mark Frydenberg

  109. Penile Gangrene: A Separate Entity from Fournier's Syndrome?

    Article • British Journal of Urology, June 1988, Wiley

    Professor Mark Frydenberg